TG Therapeutics TGTX Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's interest paid?
- TG Therapeutics (TGTX) reported interest paid of $2.39M in Q1 2026.
- How has TG Therapeutics's interest paid changed year-over-year?
- TG Therapeutics's interest paid decreased by 61.2% year-over-year, from $6.14M to $2.39M.
- What is the long-term trend for TG Therapeutics's interest paid?
- Over 3 years (2021 to 2025), TG Therapeutics's interest paid has grown at a 91.3% compound annual growth rate (CAGR), from $3.47M to $24.25M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.